Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
26.06
+0.05 (0.19%)
Feb 26, 2026, 12:08 PM EST - Market open
Tandem Diabetes Care Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$26.95
Upside
+3.42%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +91.86% | Feb 23, 2026 |
| Truist Securities | Truist Securities | Hold Reiterates $24 → $27 | Hold | Reiterates | $24 → $27 | +3.61% | Feb 23, 2026 |
| Mizuho | Mizuho | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | -15.58% | Feb 20, 2026 |
| UBS | UBS | Hold Maintains $17 → $22 | Hold | Maintains | $17 → $22 | -15.58% | Feb 20, 2026 |
| Stifel | Stifel | Hold Maintains $20 → $22 | Hold | Maintains | $20 → $22 | -15.58% | Feb 20, 2026 |
| B of A Securities | B of A Securities | Sell → Hold Upgrades $15 → $30 | Sell → Hold | Upgrades | $15 → $30 | +15.12% | Feb 20, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $14 → $21 | Hold | Maintains | $14 → $21 | -19.42% | Feb 20, 2026 |
| Stifel | Stifel | Hold Maintains $16 → $20 | Hold | Maintains | $16 → $20 | -23.25% | Feb 4, 2026 |
| Bernstein | Bernstein | Hold Maintains $18 → $25 | Hold | Maintains | $18 → $25 | -4.07% | Jan 9, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $24 | Hold | Maintains | $17 → $24 | -7.90% | Dec 18, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 → $35 | Strong Buy | Maintains | $24 → $35 | +34.31% | Dec 17, 2025 |
| Mizuho | Mizuho | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | -19.42% | Dec 17, 2025 |
| Baird | Baird | Hold → Buy Upgrades $18 → $30 | Hold → Buy | Upgrades | $18 → $30 | +15.12% | Dec 16, 2025 |
| Citigroup | Citigroup | Hold Maintains $16 → $22 | Hold | Maintains | $16 → $22 | -15.58% | Dec 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $23 | Hold | Maintains | $17 → $23 | -11.74% | Dec 2, 2025 |
| Barclays | Barclays | Buy Maintains $51 → $55 | Buy | Maintains | $51 → $55 | +111.05% | Nov 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.